DOKTER DYMPHNA DEVRIENDT
ActiveDOKTER DYMPHNA DEVRIENDT has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €135k and a net result of €93k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 95% of 16527 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
92
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency100▲+51
Growth78▲+20
Track record100
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €12k at 30 days acceptable
Liquidity ample (current ratio 20.27 against 1.57 in 2024; short-term debt: 2.9% and cash: 20% of total assets), and 2.9% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Eight signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
97.1%
Return on assets
66.8%
Age of the figures
9 mo
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025Equity per financial year
19202122232425
2019 to 2025 · latest year €135k
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 08-05-2026, 84 days ahead of the deadline.
NBB · 7 filingsDeviation from the deadline
2025
84 d early
2024
34 d early
2023
29 d early
2022
42 d early
2021
89 d early
2020
40 d early
2019
30 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
21-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€135k▲ 220%
2024 · €42k
2019: €64k
2020: €124k
2021: €179k
2022: €15k
2023: €38k
2024: €42k
2019 → 2025
Total assets
€139k▼ 19.9%
2024 · €174k
2019: €103k
2020: €173k
2021: €223k
2022: €152k
2023: €124k
2024: €174k
2019 → 2025
Net result
€93k▼ 6.0%
2024 · €99k
2019: €62k
2020: €62k
2021: €55k
2022: €66k
2023: €73k
2024: €99k
2019 → 2025
Working capital
€78k▲ 39.6%
2024 · €56k
2019: €82k
2020: €132k
2021: €195k
2022: €34k
2023: €44k
2024: €56k
2019 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€179k-€15k▼ 91.5%€38k▲ 150%€42k▲ 10.6%€135k▲ 220%
Operating result€71k-€86k▲ 20.8%€94k▲ 9.3%€130k▲ 38.5%€119k▼ 8.5%
Net result€55k-€66k▲ 20.8%€73k▲ 9.9%€99k▲ 35.8%€93k▼ 6.0%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 8% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €139k
Fixed assets
€58k▲ 180%
Current assets
€82k▼ 46.7%
Equity and liabilities €139k
Equity
€135k▲ 220%
Debt
€4k▼ 96.9%
The debt ratio falls from 75.7% to 2.9%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€125k▼
2024 · €134k
Cash flow
€99k▼
2024 · €103k
Solvency
97.1%▲
2024 · 24.3%
Current ratio
20.27▲
2024 · 1.57
Quick ratio
20.27▲
2024 · 1.57
Debt / equity
0.03▼
2024 · 3.12
ROE
68.8%▼
2024 · 234.5%
ROA
66.8%▲
2024 · 57.0%
Interest coverage
598.44▲
2024 · 193.60
Debt
€4k▼
2024 · €132k
Debt ≤ 1 year
€4k▼
2024 · €98k
Income taxes
€26k▼
2024 · €30k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€174k€139k▼
Fixed assets21/28€21k€58k▲
Tangible fixed assets22/27€21k€32k▲
Land and buildings22€13k€12k▼
Plant, machinery and equipment23-€4k
Furniture and vehicles24€413€8k▲
Other tangible fixed assets26€7k€7k▲
Financial fixed assets28-€26k
Current assets29/58€153k€82k▼
Amounts receivable within one year40/41€25k€30k▲
Trade receivables40-€11k
Other amounts receivable41€25k€18k▼
Current investments50/53€37k€23k▼
Cash at bank and in hand54/58€17k€28k▲
Deferred charges and accrued income490/1€74k€840▼
Equity and liabilities
Total equity and liabilities10/49€174k€139k▼
Equity10/15€42k€135k▲
Contributions10/11€3k€3k=
Reserves13€39k€132k▲
Distributable reserves133€39k€132k▲
Profit (loss) carried forward14€0€0=
Amounts payable17/49€132k€4k▼
Amounts payable after more than one year17€0-
Other amounts payable178/9€0-
Amounts payable within one year42/48€98k€4k▼
Trade debts44€3k€4k▲
Suppliers440/4€3k€4k▲
Taxes, remuneration and social security45€14k€0▼
Taxes450/3€14k€0▼
Other amounts payable47/48€81k€162▼
Accrued charges and deferred income492/3€34k€0▼
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€4k€6k▲
Other operating charges640/8€839€862▲
Gross operating margin9900€135k€126k▼
Operating profit (loss)9901€130k€119k▼
Financial income75/76B€59€838▲
Recurring financial income75€59€838▲
Financial charges65/66B€691€209▼
Recurring financial charges65€691€209▼
Profit (loss) for the period before taxes9903€129k€119k▼
Income taxes67/77€30k€26k▼
Profit (loss) for the period9904€99k€93k▼
Profit (loss) for the period to be appropriated9905€99k€93k▼
Appropriation of the result
Profit (loss) to be appropriated9906€99k€93k▼
Transfer to equity691/2€4k€93k▲
To other reserves6921€4k€93k▲
Profit to be distributed694/7€95k€0▼
Return on contributions (dividend)694€95k€0▼
The notes to these accounts (11 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
08-05
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Liquidity times 13current ratio 20.27
Current ratio from 1.57 to 20.27; short-term debt falls from €98k to €4k.
31-12
Financial
Equity above €100kEq €135k ▲220%
7 profitable years in a row build equity to €135k.
27-06
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Highest result since 2019net €99k ▲35.8%
Operating result €130k, net result €99k, both a record.
02-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
19-06
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
03-05
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
31-12
Financial
Weakest financial yearnet €55k ▼11.3%
Net result drops to €55k, the lowest in the series; recovery starts the following year.
31-12
Financial
Liquidity triplescurrent ratio 13.21
Current ratio from 4.68 to 13.21; short-term debt falls from €36k to €16k.
31-12
Financial
Equity above €150kEq €179k ▲44.4%
3 profitable years in a row build equity to €179k.
21-06
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
31-12
Financial
Equity above €100kEq €124k ▲95.1%
2 profitable years in a row build equity to €124k.
01-07
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Hechtel-Eksel · 2 establishment units since 2019
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
De Heerdgang 633940 Hechtel-EkselGround area
1,678 m²
Building footprint
343 m²
2 parcels, Flanders. Linked by address, not a title deed.
2 establishment units
DOKTER DYMPHNA DEVRIENDT
since 20192.292.305.285
Dokter Dymphna Devriendt
since 20202.308.502.703
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 72013A0502/00V002 | Flanders | 950 m² | 1 · 146 m² | - |
| 72019A0360/00N000 | Flanders | 728 m² | 1 · 197 m² | 0.0 m |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Dokter Jeroen Egas
BE 0753.807.586
Hoogstraten · Eq €135k
Essoh Médic
BE 0847.629.055
Genappe · Eq €135k
YAZ MEDICAL
BE 1003.625.247
Brussel · Eq €135k
HELMED
BE 0781.879.782
Schaarbeek · Eq €135k
Dr. Manolito De Bruycker
BE 0768.754.593
Berlare · Eq €135k
Of 9,124 companies in sector 86210 we hold annual accounts for 6,337. 5,443 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded14-08-2019
Fiscal year end31-12
Activities, NACEBEL
86210General medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 7 filingsAddress and cadastre registers
Data from official sources, last processed on 20-09-2026. Scores and ratios are computed by Checked and are not a credit decision.